Articles by tag: oncology-breakthrough

RNA vaccine against pancreatic cancer: breakthrough 2025

Chinese mRNA vaccine iNeo-Vac-R01 suppresses metastases. Analysis of efficacy, cost, and risks. Find out who will benefit from the new therapy.

New drug combination for lung cancer therapy: European approval

European Commission approved Zepzelca and atezolizumab combination for aggressive lung cancer. 27% reduction in risk of death. Learn details about the new standard of therapy.

Genetically modified virus stopped pancreatic cancer: breakthrough

Oncolytic adenovirus from the University of Minnesota halted tumor growth in three patients with pancreatic cancer. Learn about the mechanism, risks, and prognosis.

ADC drugs against resistant small cell lung cancer: breakthrough 2026

New class of ADC drugs targets DLL3 and B7-H3, overcoming SCLC resistance. Analysis of efficacy, toxicity, and treatment prospects. Read more.